Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Non-live trivalent influenza vaccine for one-dose intradermal delivery

Non-live trivalent influenza vaccine for one-dose intradermal delivery

US Patent 8557251 · Granted Oct 15, 2013

Estimated economic value: $16,327,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pneumococcal capsular saccharide conjugate vaccine2022
Vaccine2020
Vaccine comprising Streptococcus pneumoniae capsular polysaccharide conjugates2019
Pneumoccal polysacchride conjugate vaccine2018
Vaccine2017
Vaccine comprising Streptococcus pneumoniae capsular polysaccharide conjugates2017
Vaccine comprising Streptococcus pneumoniae capsular polysaccharide conjugates2017
Polyanionic polymer adjuvants for Haemophilus influenzae B saccharide vaccines2016
Methods for one-dose intradermal delivery for non-live trivalent influenza vacci2015
Methods for one-dose intradermal delivery for non-live trivalent influenza vacci2015
Methods for one-dose intradermal delivery for non-live trivalent influenza vacci2015
Pneumococcal polysaccharide conjugate vaccine2015